AMY PARROTT: Open Payments
NPI 1275382913 · AIKEN, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$993 in 39 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $628 · 2025 $993
Food & beverage: $993
| Company | Payments | Amount |
|---|---|---|
| BETA BIONICS, INC. | 9 | $265 |
| Calliditas Therapeutics US Inc. | 5 | $146 |
| Novo Nordisk Inc | 2 | $129 |
| SCPHARMACEUTICALS INC. | 4 | $70 |
| Travere Therapeutics, Inc. | 3 | $70 |
| Ardelyx, Inc. | 3 | $69 |
| Amgen Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
Products named: iLet Bionic Pancreas, TARPEYO, FUROSCIX, IBSRELA, TAVNEOS, FARXIGA, Kerendia, Ozempic.
Industry payments across SC — which companies pay providers there.
